Events

Planova™ Workshops and Local Seminars

The Planova™ Workshop is an opportunity for Planova™ users to share experiences and to learn the best practices of virus filtration. Event chairs and speakers at this annual event are key industry leaders in biotherapeutics, and their presentations cover topics such as tips for process optimization, validations, regulatory requirements and scaling up to commercial manufacturing. Event attendees include experts in the fields of regulation, process development, pathogen safety, quality and manufacturing. Since the first Planova™ Workshop held in 1998 in Oslo, Norway, this annual event has greatly contributed to raising awareness on viral safety as well as effective use of virus filtration in the manufacturing processes of biotherapeutics.

Planova™ Local Seminars are similar events tailored to the needs of certain local regions, with additions of presentations covering case studies from global and local companies as well as regulatory updates on viral safety specific to the region.

In this Page, you can explore details of the upcoming events as well as download materials available from past events (login required).

For more information about the virtual symposium, please visit the Seminars page.

Upcoming Events

Below you can find details of the upcoming events, including registration forms once they are available.

The 24th Planova™ Workshop

Nov 16, 2023 to Nov 17, 2023
Florence, Italy

Explore

Latest Workshops

Below you can find details of the last six Planova™ Workshops and download the presentation materials (login required). To find information on other previous Planova™ Workshops, click Archive.

Archives

Latest Seminars

Below you can find details of the last six Local Seminars and download the presentation materials (login required). To find information on other previous Local Seminars, click Archive.

Archives

Search Presentations

Here you can search and download (login required) presentation materials from past Planova™ Workshops, by entering keyword or by using filters for each category.

Keyword

Filter by Protein Type

Filter by Contents

Filter by Products

You need to log in to download the files.

156 Results Found

  1. 10
  2. 20
  3. 30
  4. All

  1. Validation of Virus Filtration Steps - Practical Aspects for Optimization of the Study Design Leading to Optimal Results -

    Olaf Stamm, Senior Specialist, Biopharmaceutical Services, Charles River
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  2. Preparation of Plasma Meeting Requirements for Contract or Domestic Fractionation

    Thierry Burnouf, Director, Human Protein Process Sciences
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  5. Plasma Fractionation - Current Technologies and New Trends -

    Sami Chtourou, Senior Vice President, Innovation and Scientific Affairs, LFB Biotechnologies
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  6. Biotherapeutics and Virus Safety: Relevant Regulations and Guidelines

    Herbert Dichtelmüller, ViruSafe-Consult
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  7. Application of Planova™ Virus Filters in MAb Purification Processes - Impact on Virus Safety and Process Performance -

    Franz Nothelfer, Associate Director, Purification Development, Boehringer Ingelheim Pharma GmbH & Co. KG
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

    Related Presentations

  8. Improvement of MAb Production Cost

    Sami Chtourou, Senior Vice President, Innovation and Scientific Affairs, LFB Biotechnologies
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  9. Ensuring Viral Safety in Recombinant Biotherapeutics

    Sudip Kumar Majumder, Principal Scientist & Head, Downstream Process Development, Intas Biopharmaceuticals Limited
    1st Planova™ Workshop in India
    Jan 31, 2013
    Goa

  10. Investigations of PCV Removal by Planova™ 15N Filters and Planova™ Filters with Pore Size Smaller than 15 nm

    Natascha Hodosi, GLP Study Director, ViruSure
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

    Related Presentations

  11. Asahi Gold Particle Test System Development and Implementation Case Study

    Kimo Sanderson, Vice President, Client Services, Asahi Kasei Bioprocess
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

  12. Use of Porcine Circovirus as a Challenge for Filtration and Other Virus Risk Mitigation Steps

    Kathryn Martin Remington, Principal Scientist, Clearance Services, BioReliance
    17th Planova™ Workshop
    Dec 12, 2014 to Dec 13, 2014
    Washington, D.C.

  13. Virus Filtration and Biotechnology Processes

    Thomas Kreil, Associate Professor of Virology at the Medical University of Vienna and Senior Director, Global Pathogen Safety, Baxter BioScience
    17th Planova™ Workshop
    Jun 12, 2014 to Jun 13, 2014
    Washington, D.C.

  14. Perspective of Plasma-Derived Products in China

    LIU Wenfang, Professor, Institute of Blood Transfusion, Chinese Academy of Medical Sciences/ Peking Union Medical College
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  15. Pathogen Safety of Biological Medicinal Products

    Thomas R.KREIL, Associate Professor of Virology, Senior Director Global Pathogen Safety, BaxterBioScience
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  16. State of the Art Approaches to Ensure Pathogens Safety of Plasma-Derived Products -an Industry Perspective

    Thierry BURNOUF, Director, Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University, Taiwan
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  17. Planova™ Filters: Virus Removal from Bio-therapeutic Products

    LIU Zhanjie, Deputy Manager of Shanghai Representative Office, Bioprocess Division, Asahi Kasei China Co., Ltd., China
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  18. Validation of Virus Filtration Steps

    Joseph V. HUGHES, Chief Scientist, Virology, Vice President- Technical Development, WuXi AppTec Inc.
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  19. Blood Products Safety and Regulation in China

    HOU Jifeng, Head of Blood Products Division, National Institutes for Food and Drug Control
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  20. State of the Art of the IVIG Manufacturing

    Sami CHTOUROU, Executive Vice President, Innovation & Scientific Affairs, LFB Biotechnologies
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  21. Virus Safety in Blood Plasma-Derived Products-Planova™ Virus Filtration

    XU Tan, Project Manager, Research and Development Division, Chengdu Rongsheng Pharmaceuticals Co., Ltd.
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  23. Current Situation of Viral Clearance for Biological Products in China

    FU Rui, Vice Senior Investigator, Division of Laboratory Animal Monitoring, National Institutes for Food and Drug Control
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  24. State of the Art Manufacturing of Biotechnological Products

    Albrecht GROENER, Head Pathogen Safety, CSL Behring
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  25. Asahi Kasei Medical Product Development Concept

    MIYABAYASHI Tomoyuki, General Manager, Technical Marketing Department, Asahi Kasei Medical Co., Ltd.
    1st Planova™ Workshop in China
    Jan 15, 2015
    Hainan Island

  27. Optimization of Virus Removal Filtration Processes: Design of Process Parameters and Virus Validation Studies

    Tomoko HONGO-HIRASAKI, Manager, Technology Development, Bioprocess Division, Asahi Kasei Medical
    18th Planova™ Wokshop
    Oct 22, 2015 to Oct 23, 2015
    Athens

  28. Virus filtration studies and manufacturing processes: does equivalence need a fresh look?

    Andreas WIESER, Senior Laboratory Associate, Global Pathogen Safety, Baxalta
    18th Planova™ Wokshop
    Oct 22, 2015 to Oct 23, 2015
    Athens

  29. Robustness of 15 or 20 nm filtration in manufacturing processes of plasma derived medicinal products

    Anky KOENDERMAN, Staff member, R&D unit, Sanquin Plasma Products bv
    18th Planova™ Wokshop
    Oct 22, 2015 to Oct 23, 2015
    Athens

  30. Defining the Design Spaces for Robust Viral Clearance in Planova™ 20N and BioEX Filter Processes

    Daniel STRAUSS, Senior Scientist, Science and Technology, Asahi Kasei Bioprocess America
    18th Planova™ Wokshop
    Oct 22, 2015 to Oct 23, 2015
    Athens

    Related Presentations

Previous next